the market?
CYCLACEL PHARMACEUTICALS, INC.
NASDAQ: CYCC
3.25
0.07
(2.20%)
| Today's Open | $3.27 |
|---|---|
| Previous Close | $3.18 |
| Daily Range | $3.13 - $3.30 |
| 52-Week Range | $2.91 - $8.18 |
| Market Cap | $35.4M |
| P/E Ratio | -1.25 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 796,807 |
| Average Daily Volume | 290,194 |
| Current FY EPS | $0.00 |
How do you think CYCC
will perform against the market?
Top CYCC Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
July 2, 2011
With the dilutive financing today, all the pieces are in place for Cyclacel to rebound in the second half: 1. Bad news out of the way. Selciclib failed in the APPRAISE trial and will no longer weigh … More
zzlangerhans (< 20)
Submitted
May 10, 2011
Cyclacel is carving out a new spike this month, undoubtedly related to ASCO's approach. But the company's presentations are unlikely to contain meaningful new data - the SEAMLESS phase III trial of sa … More
News & Commentary
Cyclacel Announces New Stock Issue
The pharmaceutical company hopes to reap gross proceeds of around $20 million from the offering.Insiders at Lululemon and Restoration Hardware Sell Company Stock
Plus, there were noteworthy purchases at Ambit Biosciences and Cyclacel Pharmaceuticals.5 of Last Week's Biggest Losers
These five stocks bucked last week's uptrend by taking a dive.5 of Last Week's Biggest Winners
These five stocks soared over the past few days.Sector
Healthcare
Industry
Drugs
CYCLACEL PHARMACEUTICALS, INC. (CYCC) Description
A development-stage biopharmaceutical company dedicated to the discovery, development and eventual commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Website: http://www.cyclacel.com/
